» Articles » PMID: 8627177

Physiological Regulation of Early and Late Stages of Megakaryocytopoiesis by Thrombopoietin

Overview
Journal J Exp Med
Date 1996 Feb 1
PMID 8627177
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombopoietin (TPO) has recently been cloned and shown to regulate megakaryocyte and platelet production by activating the cytokine receptor c-mpl. To determine whether TPO is the only ligand for c-mpl and the major regulator of megakaryocytopoiesis, TPO deficient mice were generated by gene targeting. TPO-/- mice have a >80% decrease in their platelets and megakaryocytes but have normal levels of all the other hematopoietic cell types. A gene dosage effect observed in heterozygous mice suggests that the TPO gene is constitutively expressed and that the circulating TPO level is directly regulated by the platelet mass. Bone marrow from TPO-/- mice have decreased numbers of megakaryocyte-committed progenitors as well as lower ploidy in the megakaryocytes that are present. These results demonstrate that TPO alone is the major physiological regulator of both proliferation and differentiation of hematopoietic progenitor cells into mature megakaryocytes but that TPO is not critical to the final step of platelet production.

Citing Articles

LMAN1 serves as a cargo receptor for thrombopoietin.

Everett L, Lin Z, Friedman A, Tang V, Myers G, Balbin-Cuesta G JCI Insight. 2024; 9(24).

PMID: 39499573 PMC: 11665562. DOI: 10.1172/jci.insight.175704.


Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease.

Behrens K, Kauppi M, Viney E, Kueh A, Hyland C, Willson T Leukemia. 2024; 38(6):1342-1352.

PMID: 38491305 PMC: 11147766. DOI: 10.1038/s41375-024-02219-5.


Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.

Lee S, Zhan H Stem Cell Reports. 2024; 19(2):211-223.

PMID: 38215758 PMC: 10874852. DOI: 10.1016/j.stemcr.2023.12.004.


Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome.

Zhang M, Zhang G, Xu F, Liu M, Dong X, Qi W Glob Med Genet. 2023; 10(3):194-198.

PMID: 37565060 PMC: 10411100. DOI: 10.1055/s-0043-1771456.


Cellular niches for hematopoietic stem cells in bone marrow under normal and malignant conditions.

Omatsu Y Inflamm Regen. 2023; 43(1):15.

PMID: 36805714 PMC: 9942337. DOI: 10.1186/s41232-023-00267-5.


References
1.
Jackson C . Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood. 1973; 42(3):413-21. View

2.
Shivdasani R, Rosenblatt M, Zucker-Franklin D, Jackson C, Hunt P, Saris C . Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995; 81(5):695-704. DOI: 10.1016/0092-8674(95)90531-6. View

3.
Schuster S, Badiavas E, Costa-Giomi P, Weinmann R, ERSLEV A, Caro J . Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood. 1989; 73(1):13-6. View

4.
Hoffman R . Regulation of megakaryocytopoiesis. Blood. 1989; 74(4):1196-212. View

5.
Layton J, Hockman H, Sheridan W, Morstyn G . Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood. 1989; 74(4):1303-7. View